Epsilon Healthcare Limited · ASX:EPN
Epsilon Healthcare — Investor Presentation (June 2020)
14 slides from Epsilon Healthcare's investor presentation, Jun 12, 2020
Slide 1: Smart thinking on cannabis
THC Global Group Limited (ASX:THC) Smart thinking on cannabis Investor Presentation June 2020 1 THC GLOBAL GROUP LIMITED (ASX:THC)
Slide 2: Australia’s newest pharmaceutical company - delivered
Australia’s newest Launched Affordable Medicines Range pharmaceutical company - delivered Own Australian Bio-Pharma Factory Acquired Clinics to Increase Accessibility Complete GMP Certification (EU and TGA) Established Export Channels Launched Global Scale Medicines Supply Achieved Dominant Market P
Slide 3: Delivering in Four Core Areas
Delivering in Four Core Areas World Class Pharma Global Supply of Production Medicines Four interconnected revenue centres addressing major global barriers to industry growth Direct Patient Turnkey Cultivation Healthcare Services Solutions 3 THC GLOBAL GROUP LIMITED (ASX:THC)
Slide 4: Pharma Production Made World Class
Pharma Production Made World Class Scalable Production TGA & EU GMP Licenced Production capacity scalable up to Pharma GMP cannabis medicines 1 million patients per annum with production with full EU compliance limited additional capex. enabling export opportunities. Finished Goods Diversity Onsite
Slide 5: Pharma Production at Global Scale
Pharma Production at Global Scale THC Global Cultivation Sites Canndeo Branded Medicines Third Party Australian Growers Third Party Brands International Raw Crude Pharmaceutical API 5 THC GLOBAL GROUP LIMITED (ASX:THC)
Slide 6: Affordable and Accessible Medicines
Affordable and Accessible Medicines Canndeo 6 THC GLOBAL GROUP LIMITED (ASX:THC)
Slide 7: Opening Australia’s Prescribing Market
Opening Australia’s Prescribing Market SAS-B Approvals 10000 9000 8000 Solving the 7000 Affordability & 6000 5000 Accessibility Gap Tetra Health 4000 3000 2000 1000 0 May-19 Nov-19 Mar-20 Dec-19 Aug-19 Feb-20 Oct-19 Jun-19 Sep-19 Jan-20 Jul-19 Apr-19 Apr-20 CanndeoCare 7 THC GLOBAL GROUP LIMITED (AS
Slide 8: Capturing the New Pharma OTC Market
Order of Magnitude Volume Increase $200m+ Addressable Patient Market Capturing the New Pharma OTC Market Unprecedented opportunity to dominate a new $200m+ market White Label Canndeo Branded Opportunity Medicines 8 THC GLOBAL GROUP LIMITED (ASX:THC)
Slide 9: Exporting to Global Markets
Exporting to Global Markets Delivering a global supply of affordable quality medicines 2020 2021+ 9 THC GLOBAL GROUP LIMITED (ASX:THC)
Slide 10: Smart Businesses for the Canadian Market
Smart Businesses for the Canadian Market High growth businesses developed for the Canadian market with strong profitability potential Turnkey Cultivation Solutions Medicinal Cannabis 10 THC GLOBAL GROUP LIMITED (ASX:THC)
Slide 11: Global Management Team
Global Management Team Steven Xu Ken Charteris Jarrod White Andrew Beehag Laura Harvey Angela Maguire Diandra Phipps Sonny Didugu 11 THC GLOBAL GROUP LIMITED (ASX:THC)
Slide 12: Capital and Financial Overview
Capital and Financial Overview Key Information Recent Financials ASX Code ASX:THC Cash $2.26 million + $4m debt facility (31 March) Listing Date May 2017 Property Plant and $18.4 million Pharmaceuticals, Biotechnology Equipment (2019) GICS Classification & Life Science $4 million secured debt facili
Slide 13: Disclaimer
Disclaimer 13 THC GLOBAL GROUP LIMITED (ASX:THC)
Slide 14: Contact THC Global Group
CORPORATE OFFICE Suite 4102 Level 41 Australia Square CONTACT 264-278 George Street Sydney NSW 2000 THC GLOBAL GROUP Australia ASX:THC EMAIL corporate@thc.global WEB thc.global 14 THC GLOBAL GROUP LIMITED (ASX:THC)
Epsilon Healthcare — Investor Presentation (June 2020) on 6ix